TY - JOUR
T1 - Amiodarone attenuates fluoride-induced hyperkalemia in vitro
AU - Su, Mark
AU - Chu, Jason
AU - Howland, Mary Ann
AU - Nelson, Lewis S.
AU - Hoffman, Robert S.
PY - 2003/2/1
Y1 - 2003/2/1
N2 - Poisoning by hydrofluoric acid or fluoride salts results in hypocalcemia, hypomagnesemia, and hyperkalemia with subsequent cardiac dysrhythmias. In previous studies, quinidine attenuated fluoride-induced hyperkalemia in vitro, and enhanced survival in animals. Like quinidine, amiodarone is a potassium channel blocker, although amiodarone is more familiar to clinicians due to its recent inclusion in advanced cardiac life support (ACLS) protocols. Objectives: This in-vitro study of human erythrocytes was designed to determine whether amiodarone could attenuate fluoride-induced hyperkalemia. Methods: Six healthy volunteers each donated 60 mL of blood on three occasions. Each specimen was divided into 12 tubes, incubated at 37°C, and oxygenated with room air. An aqueous sodium fluoride (F-) solution was added to tubes 1-9. Incremental amounts of quinidine were added to tubes 1-4 (Q1-Q4) to attain calculated concentrations of 0.73 μg/mL, 1.45 μg/mL, 2.9 μg/mL, and 5.8 μg/mL, respectively. Incremental amounts of amiodarone were added to tubes 5-8 (A1-A4) to attain calculated concentrations of 0.38 μg/mL, 0.75 μg/mL, 1.5 μg/mL, and 3.0 μg/mL, respectively. Tubes 9-12 were controls for each of F-, amiodarone, quinidine alone, and no additive, respectively. Extracellular potassium concentration ([K+]) was followed, and an objective endpoint was defined as the rise in potassium concentration at 6 hours. Results: Fluoride produced a significant change in [K+] by 6 hours in all samples. Quinidine produced a J-shaped curve in its ability to attenuate the rise in [K+], with only one concentration, Q3, demonstrating significance versus tube 9 (control). Amiodarone also demonstrated a J-shaped dose-response effect, with statistical significance at A1, A2, and A3 versus tube 9 (control). There was no significant difference among the effective concentrations (Q3, A1, A2, and A3) of both drugs. Conclusions: In this in-vitro model using human blood, amiodarone and quinidine both attenuated F--induced hyperkalemia. Further study is indicated to determine whether amiodarone enhances survival in F--poisoned animals.
AB - Poisoning by hydrofluoric acid or fluoride salts results in hypocalcemia, hypomagnesemia, and hyperkalemia with subsequent cardiac dysrhythmias. In previous studies, quinidine attenuated fluoride-induced hyperkalemia in vitro, and enhanced survival in animals. Like quinidine, amiodarone is a potassium channel blocker, although amiodarone is more familiar to clinicians due to its recent inclusion in advanced cardiac life support (ACLS) protocols. Objectives: This in-vitro study of human erythrocytes was designed to determine whether amiodarone could attenuate fluoride-induced hyperkalemia. Methods: Six healthy volunteers each donated 60 mL of blood on three occasions. Each specimen was divided into 12 tubes, incubated at 37°C, and oxygenated with room air. An aqueous sodium fluoride (F-) solution was added to tubes 1-9. Incremental amounts of quinidine were added to tubes 1-4 (Q1-Q4) to attain calculated concentrations of 0.73 μg/mL, 1.45 μg/mL, 2.9 μg/mL, and 5.8 μg/mL, respectively. Incremental amounts of amiodarone were added to tubes 5-8 (A1-A4) to attain calculated concentrations of 0.38 μg/mL, 0.75 μg/mL, 1.5 μg/mL, and 3.0 μg/mL, respectively. Tubes 9-12 were controls for each of F-, amiodarone, quinidine alone, and no additive, respectively. Extracellular potassium concentration ([K+]) was followed, and an objective endpoint was defined as the rise in potassium concentration at 6 hours. Results: Fluoride produced a significant change in [K+] by 6 hours in all samples. Quinidine produced a J-shaped curve in its ability to attenuate the rise in [K+], with only one concentration, Q3, demonstrating significance versus tube 9 (control). Amiodarone also demonstrated a J-shaped dose-response effect, with statistical significance at A1, A2, and A3 versus tube 9 (control). There was no significant difference among the effective concentrations (Q3, A1, A2, and A3) of both drugs. Conclusions: In this in-vitro model using human blood, amiodarone and quinidine both attenuated F--induced hyperkalemia. Further study is indicated to determine whether amiodarone enhances survival in F--poisoned animals.
KW - Amiodarone
KW - Fluoride
KW - Hyperkalemia
KW - Potassium
KW - Quinidine
UR - http://www.scopus.com/inward/record.url?scp=0347927453&partnerID=8YFLogxK
U2 - 10.1197/aemj.10.2.105
DO - 10.1197/aemj.10.2.105
M3 - Article
C2 - 12574006
AN - SCOPUS:0347927453
SN - 1069-6563
VL - 10
SP - 105
EP - 109
JO - Academic Emergency Medicine
JF - Academic Emergency Medicine
IS - 2
ER -